Categories Earnings, LATEST, Other Industries

Mylan reports revenue decline in Q2; Misses earnings expectation

Mylan NV (MYL) missed analyst expectations on revenue and earnings for the second quarter of 2018. The company’s total revenues dropped 5% to $2.81 billion from last year, mainly due to a decline in existing-products sales. The drop in sales from existing products was partially offset by new product launches.

Mylan shares dropped 5% during premarket trading following the announcement.

Total revenues include net sales and other revenues, of which net sales fell 6% while other revenues improved to $52.8 million from $35.7 million last year.

On a GAAP basis, net income fell 87% to $37.5 million or $0.07 per share from the same period last year. Adjusted net income came in at $551.5 million or $1.07 per share for the quarter.

Mylan revised its guidance for the full year of 2018. The company now expects total revenues to come in at $11.25 billion to $12.25 billion, which is essentially flat at the midpoint versus full-year 2017. Adjusted EPS is expected to be $4.55 to $4.90, an increase of 4% at the midpoint when compared to last year. Adjusted free cash flow is expected to be $2.1 billion to $2.5 billion.

Mylan second quarter 2018 earnings
Mylan Q2 2018 Earnings Infographic

Net sales in North America declined mainly due to lower volumes on existing products, including EpiPen. The Europe and Rest of World segments posted sales increases with Rest of World benefiting from new product sales, particularly from the anti-retroviral therapy franchise.

During the quarter, Mylan faced an FDA inspection at its Morgantown facility and the company is making the required improvements at the plant. This, along with job cuts and product discontinuations, led to production and supply issues which affected quarterly results.

The company’s board of directors is said to be looking at strategic alternatives to deal with lower prices and volumes for many of its products in the US market.

Related: Mylan first quarter earnings 

Mylan first quarter earnings
Mylan Q1 2018 Earnings Infographic

Most Popular

Aurora Cannabis (ACB) Earnings: 3Q21 Key Numbers

Aurora Cannabis Inc. (NYSE: ACB) reported third quarter 2021 earnings results today. Total revenues fell 25% year-over-year to CAD55.1 million. Adjusted EBITDA loss amounted to CAD24 million. Cash balance as

Walt Disney (DIS) Q2 revenue down 13%; earnings beat estimates

Media behemoth The Walt Disney Company (NYSE: DIS) reported second-quarter revenues that declined from last year as customers stayed away from theatres and parks due to pandemic-related safety issues and

Three key factors that bode well for Tattooed Chef (TTCF) going forward

Shares of Tattooed Chef Inc. (NASDAQ: TTCF) have gained 57% over the past 12 months but has dropped 25% since the start of this year. The sentiment on the stock

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top